Innate Pharma (IPHYF) Short Interest Ratio & Short Volume

Short interest is the volume of Innate Pharma shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 5,800 shares of IPHYF short. Learn More on Innate Pharma's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IPHYF shares currently have a short interest ratio of 29.0. Learn More on Innate Pharma's short interest ratio.

Here is how the short interest of companies in the sector of "medical" compare to Innate Pharma: Merrimack Pharmaceuticals, Inc. (4.97%), Acrivon Therapeutics, Inc. (4.43%), Ovid Therapeutics Inc. (4.78%), Immutep Limited (1.43%), Theseus Pharmaceuticals, Inc. (2.63%), ProQR Therapeutics (0.50%), Syros Pharmaceuticals, Inc. (9.89%), NGM Biopharmaceuticals, Inc. (4.52%), Vistagen Therapeutics, Inc. (5.27%), Kinnate Biopharma Inc. (2.01%),

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

Short selling IPHYF is an investing strategy that aims to generate trading profit from Innate Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Innate Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IPHYF, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IPHYF, twice per month. The most recent reporting period available is March, 31 2024.